Author

S. Sherif

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:benchmark study· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:clustering· 1 Approach:deep learning· 1

Frequent Co-Authors

D. Bedognetti· 3 shared E. I. Ahmed· 2 shared W. Hendrickx· 2 shared A. Awad· 1 shared A. D. Sahu· 1 shared A. Jabeen· 1 shared A. Naik· 1 shared A. S. Halkola· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

D. Bedognetti

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Community Challenge to Predict Clinical Outcomes After Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

M. Mason, O. Lapuente-Santana, A. S. Halkola, W. Wang, R. Mall, X. Xiao, J. Kaufman, J. Fu, J. Pfeil, J. Banerjee, V. Chung, H. Chang, S. D. Chasalow, H. Y. Lin, R. Chai, , B. G. Vincent

The paper evaluates predictive models for immune checkpoint inhibitor outcomes in NSCLC using clinical trial data from two RCTs, finding that models combining PD-L1, TMB, and immune signatures outperform single biomarkers.

Journal of Translational Medicine · Feb 21, 2024Peer-reviewedCancer Biology

Modulation of SLFN11 induces changes in DNA Damage response

C. M. Raynaud, E. I. Ahmed, A. Jabeen, A. Sanchez, S. Sherif, T. C. Carneiro-Lobo, A. Awad, D. Awartani, A. Naik, R. Thomas, J. Decock, G. Zoppoli, D. Bedognetti, W. Hendrickx

This study shows that increasing SLFN11 expression through CRISPR-dCas9 systems enhances DNA damage response sensitivity in breast cancer cells.

bioRxiv · Apr 2, 2023 · PreprintCancer Biology

The Immune landscape of solid pediatric tumors.

S. Sherif, J. Roelands, W. Mifsud, E. Ahmed, B. Mifsud, D. Bedognetti, W. Hendrickx

This study characterizes immune subtypes in solid pediatric tumors using gene expression data, finding distinct immune signatures and survival associations.

bioRxiv · May 4, 2021Cancer Biology